Overview
As the line between beauty and medicine fades, who will define the future of skin health?
Join us for a collaborative seminar between co11ab and JLABS Singapore from Johnson & Johnson’s global incubator network, with support from Procter & Gamble, to discuss and explore the opportunities and innovation pathways in dermatology!
This joint seminar will bring together speakers from research, industry, and clinical practice to share their perspectives on the evolving landscape of dermatology, spanning across consumer health and pharmaceuticals.
As the boundaries between skincare, medical devices and therapeutics continue to blur, this seminar will examine where the biggest unmet needs lie, how companies and research institutions evaluate and partner with emerging technologies, and what it takes to translate science into clinically validated, scalable solutions in Asia.
Speakers
Dr. Fabien Cabirol, Senior Director, Open Innovation, Asia, P&G
A/Prof. Tey Hong Liang, Clinical Director, Centre for MedTech & Innovations, NHG; Co-Founder, RNAscence; Co-Creator of Suu Balm
Prof. Rachel Watson, Executive Director, A*STAR Skin Research Labs and Skin Research Institute of Singapore
Dr. Bryan Wahking, Medical Affairs Lead, Immunology/Neuroscience/Cardiopulmonary, Asia Pacific, Johnson & Johnson Innovative Medicine
Programme Agenda
1.30PM - 2.00PM: Registration
2.00PM - 2.05PM: Welcome Remarks
2.05PM - 2.15PM: Presentation on "Industry perspectives on Dermtech: Key pain points, gaps and opportunities in precision dermatology" by Dr. Fabien Cabirol
2.15PM - 3.00PM: Fireside Chat & Q&A
3.00PM - 4.00PM: Networking
Schedule
Date: 23 Mar 2026, Monday
Time: 1:30 PM - 4:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Lee Kong Chian School of Medicine, Clinical Sciences Building, 11 Mandalay Road, #16-01, 308232
Speakers
Moderator's Profile:
Dr. Fabien Cabirol, Senior Director, Open Innovation, Asia, Procter & Gamble
For over 20 years, Fabien has worked at the interface of organizations to create value from partnerships. His passion for scientific innovation and its translation to solutions that impact people’s lives has led him to focus his career on Pharma, Biotech and Consumer R&D, particularly in ingredient discovery, product innovation, and business development. Fabien has worked for a wide range of organizations including academic institutions, startups, biochemical manufacturers, and leading companies in Dermatology, Aesthetics, and Consumer Care. With this experience and an education deeply rooted in science and technology, Fabien has helped develop new and unique strategies, tailored to the culture of every organization, to create meaningful business outcomes across the innovation value chain.
Speaker's Profile:
A/Prof. Tey Hong Liang, Clinical Director, Centre for MedTech & Innovations, NHG Health
A/Prof Tey Hong Liang is the Clinical Director at the Centre for Medtech and Innovations (CMTi), NHG Health, the co-Director of Skin Research Programme at Lee Kong Chian Medicine, Nanyang Technological University, a Senior Clinician Scientist with the National Medical Research Council, and a senior consultant at the National Skin Centre, Singapore. A/Prof Tey is a clinician, scientist, innovator and entrepreneur who has created healthcare, economic and technological impact through his Research-Innovation-Enterprise work in Dermatology. Among the world's top 2% most-cited researchers (2020-2024), his works include uncovering the pathogenesis and curative treatment for a disease, institution of 3 new clinical services and 5 patent-filed treatments in Singapore, 12 patent (family) filings, 240 international publications, and >20 products, which are currently available in 16 countries.
Speaker's Profile:
Prof. Rachel Watson, Executive Director, A*STAR Skin Research Labs and Skin Research Institute of Singapore
Rachel Watson, BSc (Hons), PhD is Professor of Cutaneous Science with a distinguished career in skin research. She earned her BSc (hons) in Anatomy & Cell Biology and her PhD from the University of Sheffield. Her research focuses on the biological mechanisms of skin ageing and extracellular matrix repair, with a particular emphasis on the effects of topical retinoids. In addition to her academic role, Rachel holds adjunct positions as Chief Scientist at the National Skin Centre, Singapore, and Adjunct Professor of Cutaneous Science at the Lee Kong Chian School of Medicine, Nanyang Technological University. She currently serves as the Executive Director of A*STAR Skin Research Labs and the Skin Research Institute of Singapore.
Speaker's Profile:
Dr. Bryan Wahking, Medical Affairs Lead, Immunology/Neuroscience/Cardiopulmonary, Asia Pacific, Johnson & Johnson Innovative Medicine
Bryan Wahking is the Therapeutic Area Lead, Immunology, Infectious Diseases & Vaccines (IDV) and Pulmonary Hypertension & Cardiovascular Metabolism (PH/CVM), Regional AP Medical Affairs. Bryan has been with Janssen since 2017, initially in AP MAF Immunology then IDV and most recently in PH/CVM. Under his leadership, the therapeutic affairs MAF teams have contributed significantly to the business, fostered scientific relationships with physicians across the region, sponsored numerous educational events and insight generating activities and raised awareness for patients with rare diseases. Prior to Janssen, Bryan worked at Abbvie/Abbott Labs in SG and HK where he helped launch a Hepatitis C virus therapeutic and at Schering-Plough where he was Country Medical Director and Head of Clinical Operations for TW, HK and KR. Bryan also previously worked at Lehman Brothers in NY City where he was an investment analyst and as a family physician in T.O. and SG.
